Observations in 205 patients with cardiovascular manifestations of anaphylactic shock confirmed the belief that adrenaline is the drug of first choice in management and that colloid solutions are preferable to crystalloid solutions in volume replacement. Arrhythmias and elevated filling pressures are more common in patients with cardiac disease but the sympathetic response appears to override the cardiac effects of histamine in healthy patients.
FisherM.M., BaldoB.A.Anaphylactoid reactions during anaesthesia. Clin Anesthesiology1984; 2: 677–691.
2.
FisherM.M., and MunroI.Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg1983; 62: 559–564.
3.
FisherM.M.Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth1977; 49: 1023–1026.
4.
SmedegardG.Anaphylactic shock. Pathophysiology of Aggregate and Cytoirophic Anaphylaxis in the Monkey. Alla Universitallis Upsaliensis1980; 548: 1.
5.
KalinerM., SiglerR., SummersR., ShelhamerJ.H.Effects of infused histamine: analysis of the effects of H1 and H2 histamine receptor antagonists on cardiovascular and pulmonary responses. J Allergy Clin Immunol1981; 68: 365–371.
6.
ZaveczJ.H., LevyR.Separation of primary and secondary cardiovascular events in systemic anaphylaxis. Circulation Research1977; 40: 15–19.
7.
LorenzW., DoenickeA., SchoningB., OhmannCh. Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: Studies in the conscious human subject. Klin Wochen1982; 60: 896–913.
8.
PhilbinD.M., MossJ., AkinsC.W., RoscowC.E., SavareseJ.J.The use of H1 and H2 histamine antagonists with morphine anaesthesia. Anesthesiology1981; 55: 292–296.
9.
MossJ., FahmyN.R., SunderN., BeavenM.A.Hormonal and haemodynamic profile of an anaphylactic reaction in man. Circulation1981; 63: 210–213.
